PFE · News · 20260922N
Guidance / Outlook
PFIZER INC · 2026-09-22 · Importance 75 · Surprise 60 · In source text
Pfizer’s 2026 revenue guidance was reported at $61.5 billion. The guidance increase was attributed to strength in the non-COVID portfolio and prior acquisitions. COVID-19 product sales guidance was reduced, while new-product ramps remain an offsetting growth factor.
Key facts
- Pfizer's 2026 revenue guidance is $61.5B. source
- Pfizer invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10:00 a.m. EST on Tuesday, November 3, 2026 to provide an update on Pfizer's results, as reflected in the company's Third Quarter 2026 Performance Report. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | probable | — | Pfizer's 2026 revenue guidance is $61.5B. |